vs

Side-by-side financial comparison of Industrial Logistics Properties Trust (ILPT) and Phathom Pharmaceuticals, Inc. (PHAT). Click either name above to swap in a different company.

Industrial Logistics Properties Trust is the larger business by last-quarter revenue ($113.9M vs $57.6M, roughly 2.0× Phathom Pharmaceuticals, Inc.). On growth, Phathom Pharmaceuticals, Inc. posted the faster year-over-year revenue change (94.1% vs 3.1%). Industrial Logistics Properties Trust produced more free cash flow last quarter ($42.0M vs $-167.0M).

Industrial Logistics Properties Trust is a real estate investment trust that owns and operates a portfolio of industrial and logistics real estate assets primarily across the United States. Its holdings include distribution centers, warehouses, and last-mile delivery properties, serving e-commerce, retail, manufacturing and supply chain operators to meet their storage and logistics operation needs.

Phathom Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative therapies for gastrointestinal diseases. Its lead product candidates address acid-related disorders, inflammatory bowel disease, and other GI conditions, serving patients mainly across North America and Europe.

ILPT vs PHAT — Head-to-Head

Bigger by revenue
ILPT
ILPT
2.0× larger
ILPT
$113.9M
$57.6M
PHAT
Growing faster (revenue YoY)
PHAT
PHAT
+91.1% gap
PHAT
94.1%
3.1%
ILPT
More free cash flow
ILPT
ILPT
$209.0M more FCF
ILPT
$42.0M
$-167.0M
PHAT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ILPT
ILPT
PHAT
PHAT
Revenue
$113.9M
$57.6M
Net Profit
$-1.8M
Gross Margin
86.7%
Operating Margin
-22.1%
Net Margin
-1.6%
Revenue YoY
3.1%
94.1%
Net Profit YoY
92.6%
71.6%
EPS (diluted)
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ILPT
ILPT
PHAT
PHAT
Q4 25
$113.9M
$57.6M
Q3 25
$110.9M
$49.5M
Q2 25
$112.1M
$39.5M
Q1 25
$111.9M
$28.5M
Q4 24
$110.5M
$29.7M
Q3 24
$108.9M
$16.4M
Q2 24
$110.6M
$7.3M
Q1 24
$112.2M
Net Profit
ILPT
ILPT
PHAT
PHAT
Q4 25
$-1.8M
Q3 25
$-21.6M
$-30.0M
Q2 25
$-21.3M
$-75.8M
Q1 25
$-21.5M
$-94.3M
Q4 24
$-24.1M
Q3 24
$-25.0M
$-85.6M
Q2 24
$-23.2M
$-91.4M
Q1 24
$-23.4M
Gross Margin
ILPT
ILPT
PHAT
PHAT
Q4 25
86.7%
Q3 25
87.5%
Q2 25
87.2%
Q1 25
86.9%
Q4 24
87.1%
Q3 24
85.6%
Q2 24
81.2%
Q1 24
Operating Margin
ILPT
ILPT
PHAT
PHAT
Q4 25
-22.1%
Q3 25
-29.4%
-30.8%
Q2 25
-30.8%
-151.7%
Q1 25
-26.9%
-276.5%
Q4 24
-31.1%
Q3 24
-33.5%
-433.0%
Q2 24
-32.4%
-1055.4%
Q1 24
-31.7%
Net Margin
ILPT
ILPT
PHAT
PHAT
Q4 25
-1.6%
Q3 25
-19.4%
-60.5%
Q2 25
-19.0%
-191.9%
Q1 25
-19.2%
-330.7%
Q4 24
-21.8%
Q3 24
-22.9%
-523.3%
Q2 24
-20.9%
-1248.6%
Q1 24
-20.9%
EPS (diluted)
ILPT
ILPT
PHAT
PHAT
Q4 25
$-0.02
Q3 25
$-0.33
$-0.41
Q2 25
$-0.32
$-1.05
Q1 25
$-0.33
$-1.31
Q4 24
$-0.37
Q3 24
$-0.38
$-1.32
Q2 24
$-0.35
$-1.56
Q1 24
$-0.36

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ILPT
ILPT
PHAT
PHAT
Cash + ST InvestmentsLiquidity on hand
$94.8M
$130.0M
Total DebtLower is stronger
$4.2B
$209.1M
Stockholders' EquityBook value
$489.7M
$-438.2M
Total Assets
$5.2B
$259.1M
Debt / EquityLower = less leverage
8.56×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ILPT
ILPT
PHAT
PHAT
Q4 25
$94.8M
$130.0M
Q3 25
$83.2M
$135.2M
Q2 25
$58.6M
$149.6M
Q1 25
$108.0M
$212.3M
Q4 24
$131.7M
$297.3M
Q3 24
$153.9M
$334.7M
Q2 24
$146.2M
$276.2M
Q1 24
$128.4M
Total Debt
ILPT
ILPT
PHAT
PHAT
Q4 25
$4.2B
$209.1M
Q3 25
$4.2B
$207.1M
Q2 25
$4.2B
$205.1M
Q1 25
$4.3B
$203.2M
Q4 24
$4.3B
$201.4M
Q3 24
$4.3B
$175.7M
Q2 24
$4.3B
$174.4M
Q1 24
$4.3B
Stockholders' Equity
ILPT
ILPT
PHAT
PHAT
Q4 25
$489.7M
$-438.2M
Q3 25
$494.1M
$-422.5M
Q2 25
$519.1M
$-405.8M
Q1 25
$539.5M
$-338.4M
Q4 24
$562.0M
$-253.6M
Q3 24
$585.9M
$-187.1M
Q2 24
$618.3M
$-233.8M
Q1 24
$643.2M
Total Assets
ILPT
ILPT
PHAT
PHAT
Q4 25
$5.2B
$259.1M
Q3 25
$5.2B
$240.3M
Q2 25
$5.2B
$250.2M
Q1 25
$5.4B
$294.2M
Q4 24
$5.4B
$378.3M
Q3 24
$5.5B
$387.0M
Q2 24
$5.5B
$319.4M
Q1 24
$5.5B
Debt / Equity
ILPT
ILPT
PHAT
PHAT
Q4 25
8.56×
Q3 25
8.49×
Q2 25
8.09×
Q1 25
7.96×
Q4 24
7.65×
Q3 24
7.35×
Q2 24
6.96×
Q1 24
6.70×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ILPT
ILPT
PHAT
PHAT
Operating Cash FlowLast quarter
$60.7M
$-166.8M
Free Cash FlowOCF − Capex
$42.0M
$-167.0M
FCF MarginFCF / Revenue
36.9%
-290.0%
Capex IntensityCapex / Revenue
16.4%
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$79.8M
$-328.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ILPT
ILPT
PHAT
PHAT
Q4 25
$60.7M
$-166.8M
Q3 25
$22.7M
$-14.1M
Q2 25
$18.4M
$-62.7M
Q1 25
$11.4M
$-84.9M
Q4 24
$2.0M
$-266.8M
Q3 24
$-3.4M
$-63.6M
Q2 24
$10.8M
$-70.7M
Q1 24
$8.0M
Free Cash Flow
ILPT
ILPT
PHAT
PHAT
Q4 25
$42.0M
$-167.0M
Q3 25
$17.6M
$-14.1M
Q2 25
$15.2M
$-62.8M
Q1 25
$5.0M
$-84.9M
Q4 24
$-3.7M
$-266.9M
Q3 24
$-5.9M
$-63.6M
Q2 24
$9.4M
$-70.8M
Q1 24
$5.9M
FCF Margin
ILPT
ILPT
PHAT
PHAT
Q4 25
36.9%
-290.0%
Q3 25
15.9%
-28.6%
Q2 25
13.5%
-159.0%
Q1 25
4.5%
-297.9%
Q4 24
-3.4%
-899.8%
Q3 24
-5.5%
-389.0%
Q2 24
8.5%
-966.2%
Q1 24
5.2%
Capex Intensity
ILPT
ILPT
PHAT
PHAT
Q4 25
16.4%
0.4%
Q3 25
4.6%
0.1%
Q2 25
2.9%
0.2%
Q1 25
5.7%
0.1%
Q4 24
5.2%
0.5%
Q3 24
2.3%
0.3%
Q2 24
1.3%
0.6%
Q1 24
1.9%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons